Genmab — Januar 2019
-
Markman Advisors LLC @MarkmanAdvisors
Darzalex patent case: Court orders trial to proceed on February 19-20 on Janssen's inequitable conduct claim; Court denies MorphoSys' request to stay trial pending appeal of enablement decision. $MOR $JNJ #darzalex
20:48 - 29 jan. 2019
-
Jeg håber det sidste, Solsen...men svært at se "lyset" lige nu, hvor vi ligger og bokser rundt på kurs 960
-
Så er aktien vel også i nærheden af at matche markedsafkastet....
-
du giver godt nok gas Varnæs4
-
Yessir. Det er rettidig omhu at give sorte svaner, M&A rationale, knockyoursocksoff, peaksales in the sky osv osv lidt modspil. Virkeligheden trænger sig på
-
Jeg mangler lidt stemmer til at blive medlem af bestyrelsen...
-
Mine 2,5 mio aktier er ikke helt nok
-
Den gode skribent efterlyste jo organisationsændringer fra min hånd
-
vi kan ikke helt være med der Nohope, vores lidt over 5k aktier per mand gør sgu ikke den store forskel
-
ja, jeg mente det nok.Vi har tabt en ferrari og en lamborghini per mand siden 18 okt 2017
-
du har/havde også Pandora ikke?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind